ReviewNEJM evidence2023
Methamphetamine Toxicities and Clinical Management.
Review in NEJM evidence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06745128 (Tirzepatide for Individuals With Comorbid Obesity and Methamphetamine Use Disorder), which is not on this map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Tirzepatide for Individuals With Comorbid Obesity and Methamphetamine Use Disorder
Who cites it
15 citing papers in PubMed.
- Three-year cardiovascular risk prediction among people who use cocaine or methamphetamine.Drug and alcohol dependence reports · 2026Article
- Methamphetamine-induced inhibition of Mettl21c in undifferentiated spermatogonia impairs male fertility in mice.Asian journal of andrology · 2026Article
- Coverage Limitations for Use of Urine Drug Testing in a State Medicaid Program.JAMA network open · 2026Article
- Article
- Cardiovascular Conditions and Symptoms in Deaths Attributed to Acute Stimulant Toxicity.Circulation. Population health and outcomes · 2026Article
- Navigating 'k-land': a qualitative exploration of participants' experiences of ketamine-assisted psychotherapy for methamphetamine use disorder.Frontiers in psychiatry · 2026Article
- Article
- Clinical progress note: Management of the hospitalized patient who uses methamphetamine.Journal of hospital medicine · 2025Article
- Trends, characteristics, and circumstances surrounding stimulant toxicity deaths in Ontario, Canada from 2018 to 2021.Journal of substance use and addiction treatment · 2025Article
- Identification of Behavioral, Clinical, and Psychological Antecedents of Acute Stimulant Poisoning: Development and Implementation of a Mixed Methods Psychological Autopsy Study.JMIR formative research · 2025Article
- Management of Amphetamine and Methamphetamine Use Disorders: A Systematic Review and Network Meta-analysis of Randomized Trials.International journal of mental health and addiction · 2025Article
- Methamphetamine use and suicide risk: a comprehensive case-control study.Frontiers in public health · 2025Article
- A review of methamphetamine use and stroke in the young.Frontiers in neurology · 2024Review
- Prescribing Psychostimulants for the Treatment of Stimulant Use Disorder: Navigating the Federal Legal Landscape.Journal of addiction medicineReview
- Stimulant-Involved Cardiovascular Disease Mortality and Life Years Lost, 2014 to 2023.Substance use : research and treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Methamphetamine Toxicities and Clinical ManagementMethamphetamine increases the release and blocks the uptake of norepinephrine, serotonin, and dopamine. This article reviews the morbidity and mortality associated with methamphetamine use and discusses prevention and treatment strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.